Baxter (BAX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Baxter Revenue Highlights

Latest Revenue (Y)

$14.81B

Latest Revenue (Q)

$3.81B

Main Segment (Y)

Pharmaceuticals

Main Geography (Y)

Non-US

Baxter Revenue by Period

Baxter Revenue by Year

Date	Revenue	Change
2023-12-31	$14.81B	-1.99%
2022-12-31	$15.11B	18.22%
2021-12-31	$12.78B	9.52%
2020-12-31	$11.67B	2.74%
2019-12-31	$11.36B	2.11%
2018-12-31	$11.13B	5.36%
2017-12-31	$10.56B	3.92%
2016-12-31	$10.16B	1.96%
2015-12-31	$9.97B	-40.21%
2014-12-31	$16.67B	9.25%
2013-12-31	$15.26B	7.53%
2012-12-31	$14.19B	2.14%
2011-12-31	$13.89B	8.18%
2010-12-31	$12.84B	2.24%
2009-12-31	$12.56B	1.73%
2008-12-31	$12.35B	9.63%
2007-12-31	$11.26B	8.53%
2006-12-31	$10.38B	5.37%
2005-12-31	$9.85B	3.58%
2004-12-31	$9.51B	6.65%
2003-12-31	$8.92B	9.94%
2002-12-31	$8.11B	5.83%
2001-12-31	$7.66B	11.12%
2000-12-31	$6.90B	8.09%
1999-12-31	$6.38B	-3.32%
1998-12-31	$6.60B	7.51%
1997-12-31	$6.14B	12.87%
1996-12-31	$5.44B	7.73%
1995-12-31	$5.05B	-45.86%
1994-12-31	$9.32B	-

Baxter generated $14.81B in revenue during NA 2023, up -1.99% compared to the previous quarter, and up 133.13% compared to the same period a year ago.

Baxter Revenue by Quarter

Date	Revenue	Change
2024-06-30	$3.81B	6.12%
2024-03-31	$3.59B	-7.54%
2023-12-31	$3.88B	4.77%
2023-09-30	$3.71B	0.03%
2023-06-30	$3.71B	1.59%
2023-03-31	$3.65B	-6.12%
2022-12-31	$3.89B	3.02%
2022-09-30	$3.77B	0.72%
2022-06-30	$3.75B	1.05%
2022-03-31	$3.71B	5.49%
2021-12-31	$3.51B	8.93%
2021-09-30	$3.23B	4.13%
2021-06-30	$3.10B	5.16%
2021-03-31	$2.95B	-7.39%
2020-12-31	$3.18B	7.03%
2020-09-30	$2.97B	9.35%
2020-06-30	$2.72B	-3.00%
2020-03-31	$2.80B	-7.80%
2019-12-31	$3.04B	6.59%
2019-09-30	$2.85B	0.39%
2019-06-30	$2.84B	7.90%
2019-03-31	$2.63B	-7.36%
2018-12-31	$2.84B	2.67%
2018-09-30	$2.77B	-2.64%
2018-06-30	$2.84B	6.16%
2018-03-31	$2.68B	-3.50%
2017-12-31	$2.77B	2.48%
2017-09-30	$2.71B	3.92%
2017-06-30	$2.60B	5.25%
2017-03-31	$2.48B	-6.43%
2016-12-31	$2.65B	3.40%
2016-09-30	$2.56B	-1.04%
2016-06-30	$2.58B	8.84%
2016-03-31	$2.38B	-8.76%
2015-12-31	$2.60B	4.66%
2015-09-30	$2.49B	-36.12%
2015-06-30	$3.89B	3.43%
2015-03-31	$3.76B	-15.83%
2014-12-31	$4.47B	6.55%
2014-09-30	$4.20B	-1.57%
2014-06-30	$4.26B	7.92%
2014-03-31	$3.95B	-9.55%
2013-12-31	$4.37B	15.74%
2013-09-30	$3.77B	2.86%
2013-06-30	$3.67B	6.41%
2013-03-31	$3.45B	-8.13%
2012-12-31	$3.75B	7.94%
2012-09-30	$3.48B	-2.66%
2012-06-30	$3.57B	5.43%
2012-03-31	$3.39B	-5.73%
2011-12-31	$3.59B	3.31%
2011-09-30	$3.48B	-1.61%
2011-06-30	$3.54B	7.67%
2011-03-31	$3.28B	-6.12%
2010-12-31	$3.50B	8.50%
2010-09-30	$3.22B	0.94%
2010-06-30	$3.19B	9.12%
2010-03-31	$2.93B	-15.65%
2009-12-31	$3.47B	10.33%
2009-09-30	$3.15B	0.70%
2009-06-30	$3.12B	10.59%
2009-03-31	$2.82B	-9.81%
2008-12-31	$3.13B	-0.63%
2008-09-30	$3.15B	-1.19%
2008-06-30	$3.19B	10.84%
2008-03-31	$2.88B	-

Baxter generated $3.81B in revenue during Q2 2024, up 6.12% compared to the previous quarter, and up 104.47% compared to the same period a year ago.

Baxter Revenue Breakdown

Baxter Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 18
Pharmaceuticals	$2.25B	$2.09B	-	-
Hillrom	-	$2.94B	$212.00M	-
Acute Theapies	-	-	-	$517.00M
Advanced Surgery	-	-	-	$800.00M
Clinical Nutrition	-	-	-	$877.00M
Medication Delivery	-	-	-	$2.67B
Other Product Or Services	-	-	-	$510.00M
Renal	-	-	-	$3.66B

Baxter's latest annual revenue breakdown by segment (product or service), as of Dec 23: Pharmaceuticals (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
Medical Products And Therapies	$272.00M	$263.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Healthcare Systems and Technologies	$296.00M	$265.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Kidney Care	-	$214.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pharmaceuticals	-	$578.00M	$1.67B	$580.00M	$540.00M	$519.00M	$537.00M	$496.00M	-	-	-	-	-	-	-	-	-	-
Hillrom	-	-	-	-	$743.00M	$731.00M	$735.00M	$715.00M	$755.00M	-	-	-	-	-	-	-	-	-
E M E A Segment	-	-	-	-	$762.00M	$714.00M	$692.00M	$738.00M	$699.00M	$779.00M	$783.00M	$738.00M	-	-	-	-	-	-
E M E A	-	-	-	-	-	-	-	-	-	-	-	-	$744.00M	$705.00M	-	-	-	-
Acute Theapies	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$137.00M	$122.00M	$129.00M	$129.00M
Advanced Surgery	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$214.00M	$200.00M	$204.00M	$182.00M
Clinical Nutrition	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$215.00M	$218.00M	$221.00M	-
Medication Delivery	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$660.00M	$652.00M	$681.00M	$676.00M
Other Product Or Services	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$122.00M	$146.00M	$139.00M	$103.00M
Renal	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$953.00M	$910.00M	$931.00M	$868.00M
Nutrition	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$223.00M

Baxter's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Healthcare Systems and Technologies (52.11%), and Medical Products And Therapies (47.89%).

Baxter Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
UNITED STATES	$7.00B	-	-	-	-
Non-US	$7.81B	-	-	-	-
Latin America And Canada	-	$1.43B	$1.25B	$1.19B	$1.27B
EMEA	-	$3.71B	$3.55B	$3.13B	$2.97B
Asia Pacific	-	$2.75B	$2.80B	$2.48B	$2.30B
Americas	-	-	-	$6.07B	$6.09B

Baxter's latest annual revenue breakdown by geography, as of Dec 23: Non-US (52.74%), and UNITED STATES (47.26%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19
UNITED STATES	$1.50B	$1.66B	$5.16B	$1.77B	$35.00M	$38.00M	$34.00M	$38.00M	$36.00M	$37.00M	$203.00M	$222.00M	$217.00M	$216.00M	$1.29B	$216.00M	$209.00M	$204.00M	$199.00M	$1.19B
EMEA	$347.00M	$778.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Western Europe, Canada, Japan, Australia and New Zealand	$852.00M	$1.16B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-US	-	$1.93B	$5.79B	$1.94B	$42.00M	$43.00M	$47.00M	$38.00M	$33.00M	$41.00M	$401.00M	$759.00M	$747.00M	$706.00M	$739.00M	$710.00M	$666.00M	$719.00M	-	-
Non Us	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.65B

Baxter's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (55.58%), Western Europe, Canada, Japan, Australia and New Zealand (31.57%), and EMEA (12.86%).

Baxter Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BDX	Becton, Dickinson and Company	$20.18B	$4.99B
BAX	Baxter	$14.81B	$3.81B
ALC	Alcon	$10.09B	$2.46B
RMD	ResMed	$4.69B	$1.22B
HOLX	Hologic	$4.03B	$1.01B
COO	Cooper Companies	$3.90B	$1.00B
TFX	Teleflex	$2.97B	$764.38M
WST	West Pharmaceutical Services	$2.95B	$746.90M
NVST	Envista	$2.57B	$884.70M
ICUI	ICU Medical	$2.26B	$589.13M
MMSI	Merit Medical Systems	$1.26B	$339.85M
EMBC	Embecta	$1.12B	$272.50M

BAX Revenue FAQ

What is Baxter’s yearly revenue?

Baxter's yearly revenue for 2023 was $14.81B, representing a decrease of -1.99% compared to 2022. The company's yearly revenue for 2022 was $15.11B, representing an increase of 18.22% compared to 2021. BAX's yearly revenue for 2021 was $12.78B, representing an increase of 9.52% compared to 2020.

What is Baxter’s quarterly revenue?

Baxter's quarterly revenue for Q2 2024 was $3.81B, a 6.12% increase from the previous quarter (Q1 2024), and a 2.83% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $3.59B, a -7.54% decrease from the previous quarter (Q4 2023), and a -1.56% decrease year-over-year (Q1 2023). BAX's quarterly revenue for Q4 2023 was $3.88B, a 4.77% increase from the previous quarter (Q3 2023), and a -0.05% decrease year-over-year (Q4 2022).

What is Baxter’s revenue growth rate?

Baxter's revenue growth rate for the last 3 years (2021-2023) was 15.87%, and for the last 5 years (2019-2023) was 30.37%.

What are Baxter’s revenue streams?

Baxter's revenue streams in c 23 are Pharmaceuticals

What is Baxter’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Baxter was Pharmaceuticals. This segment made a revenue of $2.25B, representing 100.00% of the company's total revenue.